Showing results (3941-3950 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|August 13, 2009
Factors interacting with HIF-1alpha mRNA: novel therapeutic targetsStefanie Galbán, Myriam GorospeCurrent Pharmaceutical Design|August 13, 2009
Regulation of HIF-1alpha at the transcriptional levelAgnes GörlachCurrent Pharmaceutical Design|August 20, 2009
Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imagingO D Howes, A Egerton, V Allan, et al.Current Pharmaceutical Design|August 20, 2009
Recombinant immunotoxins for the treatment of chemoresistant hematologic malignanciesRobert J KreitmanCurrent Pharmaceutical Design|August 20, 2009
Fcgamma receptor 1 (CD64), a target beyond cancerT Thepen, M Huhn, G Melmer, et al.Current Pharmaceutical Design|August 20, 2009
Vitamin D deficiency: the invisible accomplice of metabolic endotoxemia?Paul Lee, Lesley V CampbellCurrent Pharmaceutical Design|August 20, 2009
Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseasesMasafumi Takahashi, Atsushi Izawa, Yoshiaki Ishigatsubo, et al.Current Pharmaceutical Design|July 16, 2009
Metabolite identification and profiling in drug design: current practice and future directionsZhoupeng Zhang, Mingshe Zhu, Wei TangCurrent Pharmaceutical Design|July 16, 2009
A review of the ADAMTS family, pharmaceutical targets of the futureMicky D Tortorella, Fransiska Malfait, Ruteja A Barve, et al.Current Pharmaceutical Design|July 16, 2009
The roles of antimicrobial peptides in innate host defenseGill Diamond, Nicholas Beckloff, Aaron Weinberg, et al.Pageof 1,008